Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| BNP Paribas | 3.94% | $12.22M | €96.10B | 42.34% | 77 Outperform | |
| AstraZeneca | 3.65% | $11.34M | $298.79B | 46.68% | 79 Outperform | |
| ORANGE SA | 3.65% | $11.33M | €38.65B | 40.44% | 65 Neutral | |
| NN Group N.V. | 3.36% | $10.43M | €16.70B | 61.09% | 68 Neutral | |
| Mitsubishi UFJ Financial Group | 3.30% | $10.25M | ¥32.20T | 52.05% | 76 Outperform | |
| E.ON SE | 3.27% | $10.14M | €44.25B | 58.56% | 61 Neutral | |
| Roche Holding AG | 3.21% | $9.95M | CHF275.00B | 44.94% | 73 Outperform | |
| ING GROEP | 2.97% | $9.22M | €70.95B | 58.18% | 61 Neutral | |
| TotalEnergies SE | 2.87% | $8.90M | €123.09B | -2.76% | 78 Outperform | |
| Enel S.p.A. | 2.71% | $8.41M | €94.67B | 31.91% | 67 Neutral |